Wall Street bounced back on Tuesday, recouping some recent losses, as investors sought cheap assets after a two-day equities rout sparked by Britain's decision to leave the European Union.
US indexes joined stock markets around the world in the rebound after global equity markets had shed $3 trillion in value in the two days following Britain's shock vote, according to S&P Dow Jones Indices. Investors also pointed to solid US economic data as helping to stabilise stocks.
Financials and tech stocks, hit hard in the wake of the referendum, were among the top gaining sectors on Tuesday.
“People are starting to say maybe this is going to take longer than they thought and maybe the impacts on the US market won't be nearly as great as feared,” said Rick Meckler, president of LibertyView Capital Management in Jersey City, New Jersey. “So I think you've seen a bit of bargain-hunting.”
The Dow Jones industrial average rose 269.48 points, or 1.57 per cent, to 17,409.72, the S&P 500 gained 35.55 points, or 1.78 per cent, to 2,036.09 and the Nasdaq Composite added 97.42 points, or 2.12 per cent, to 4,691.87.
All 10 S&P sectors finished higher. Energy shares gained 2.6 per cent, leading all groups, supported by higher oil prices.
Major US indexes had posted their worst two-day decline in 10 months following the British referendum.
Volatility expected
Investors are still bracing for volatility in the coming weeks amid uncertainty about how Britain will pursue its EU exit, with some pointing to more possible downside. The S&P 500 was within 17 points of its May 2015 record high last Thursday.
Still, the CBOE Volatility Index, the favored gauge of investor anxiety, fell about 21 per cent to trade close to where it was before the Brexit vote. It was its largest one-day percentage decline since August 2011.
Economic growth
Data on Tuesday showed US economic growth slowed in the first quarter but not as sharply as previously estimated. A report from the Conference Board showed consumer confidence increased to an eight-month high in June.
The data “reminded people that the US economy is still in very good shape and sort of refocused everybody on the bigger picture, and let's step back from the edge with regard to Brexit,” said John Traynor, chief investment officer of People's United Wealth Management in Bridgeport, Connecticut.
Gilead Sciences shares gained 5.2 per cent after the large biotechnology company won US approval for a hepatitis C medicine.
Endo International shares surged 18.3 per cent, the top performer on the S&P 500, as the drugmaker announced a new patent.
More than 8.2 billion shares changed hands in US exchanges, above the roughly 7.5 billion average over the past 20 sessions.
Advancing issues outnumbered declining ones on the NYSE by 2,644 to 440, for a 6.01-to-1 ratio on the upside; on the Nasdaq, 2,302 issues rose and 580 fell for a 3.97-to-1 ratio favouring advancers.
The S&P 500 posted 16 new 52-week highs and 2 new lows; the Nasdaq recorded 22 new highs and 50 new lows.